Why big pharma has abandoned antibiotics
Despite the clear need for more antimicrobial agents, such drugs have not been forthcoming. Fewer new antibiotics are reaching the market; the last entirely original class of antibiotic was discovered in the late 1980s. One reason is that discovering and bringing antibiotics to market is often not profitable for pharmaceutical companies.
Join the AMR Insights Ambassador Network today!
Connect to over 650 AMR professionals and students in 65 countries!